Filing Flows › Health Care › Aclarion (ACON)

Aclarion (ACON) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · Aclarion (ACON) Q3 2026 earnings results →

Q3 2026 Revenue up 78% year over year to $34K

Aclarion made $34K in Q3 2026 (+78% Y/Y). Operating margin n/m, net loss $2.6M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.

Revenue$34K

Year over year+78%

Operating marginn/m

Net earnings−$2.6M

Operating cash flow−$2.0M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $34K in Q3 2026, up 78% year over year and up 34% from the previous quarter.

Gross margin was 43.9%, up 20.7 points from a year earlier. Operating costs exceeded revenue by $2.8M, an operating margin of -8164.7%. Operating expenses grew 51% against revenue growth of 78%. The fastest-growing cost line was General & admin (+82%). The quarter ended with a net loss of $2.6M, narrower than the previous quarter's $2.7M loss.

Operating cash flow was −$2.0M. Non-cash charges added back $64K of depreciation and amortization and $425K of share-based compensation. Working capital and other items added $115K.

Quarterly history

Quarter	Form	Filed	Revenue	Y/Y	Op. margin	Net earnings	Op. cash flow
Q3 2026	10-Q	Nov 5, 2026	$34K	+78%	n/m	−$2.6M	−$2.0M
Q2 2026	10-Q	Aug 6, 2026	$25K	+30%	n/m	−$2.7M	−$2.7M

Charts

From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.

Latest (Q3 2026): Net income −$2.6M, Operating cash flow −$2.0M.

-41.3% since FY2021: buybacks shrank the count.

Services-Medical Laboratories; dot size is quarterly revenue; dashed lines are the industry's medians.